T1	Treatment 251 351	group 1--197 patients given single-dose ceftriaxone (2 gm.), group 2--203 patients given 160/800 mg.
T2	Treatment 352 442	trimethoprimsulfamethoxazole and group 3--199 controls given no antimicrobial prophylaxis.
